Neoadjuvant Therapy Improves Survival in Metastatic Colon Cancer

Among patients with metastatic colon cancer with liver or lung lesions who received neoadjuvant therapy, survival was longer in comparison with patients who received adjuvant therapy, but only in nonacademic settings.
Medscape Medical News

source https://www.medscape.com/viewarticle/984301?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?